New Indications and New Reoperative Surgical Technologies for Second Lok Surgery in Colorectal Cancer

• Autorzy: Paul Sugarbaker
• Języki publikacji: EN

Abstrakty

EN

• Wydawca: Index Copernicus International
• Czasopismo: Polish Journal of Surgery
• Rocznik: 2010
• Tom: 82
• Numer: 9
• Strony: 526-535

Daty

wydano

2010-09-01

online

2010-10-22

Twórcy

autor

Paul Sugarbaker

• Washington Cancer Institute, Washington, DC, USA

Bibliografia

• Osteen RT, Guyton S, Steele G Jr et al.: Malignant intestinal obstruction. Surgery 1980; 87: 611-15.
• Walsh HPJ, Schofield PF: Is laparotomy for small bowel obstruction justified in patients with previously treated malignancy? Br J Surg 1984; 71: 933-35.
• Spears H, Petrelli NJ, Herrera L et al.: Treatment of bowel obstruction after operation for colorectal carcinoma. Am J Surg 1998; 155: 383-86.
• Butler JA, Cameron BL, Morrow M et al.: Small bowel obstruction in patients with a prior history of cancer. Am J Surg 1991; 162: 624-28.
• Gwin JL, Hoffman JP, Eisenberg BL: Surgical management of nonhepatic intra-abdominal recurrence of carcinoma of the colon. Dis Colon Rectum 1993; 36: 540-44.
• Gilbertsen VA, Wangensteen OH: A summary of thirteen years' experience with the second look program. Surg Gynecol Obstet 1962; 114: 438-42.
• Minton JP, Hoehn JL, Gerber DM et al.: Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study. Cancer 1985; 55: 1284-90.
• Griffen WO, Humphrey L, Sosin H: The prognosis and management of recurrent abdominal malignancies. Curr Probl Surg 1969; Apr: 1-43.
• Wangensteen OH: Cancer of the colon and rectum; with special reference to earlier recognition of alimentary tract malignancy; secondary delayed re-entry of the abdomen in patients exhibiting lymph node involvement; subtotal primary excision of the colon; operation in obstruction. Wis Med J 1949; 48: 591-97.
• Sugarbaker PH, Zamcheck N, Moore FD: Assessment of serial carcinoembryonic antigen (CEA) assays in postoperative detection of recurrent colorectal cancer. Cancer 1976; 38: 2310-15.
• Steele G Jr, Zamcheck N, Wilson R et al.: Results of CEA-initiated second-look surgery for recurrent colon cancer. Am J Surg 1980; 139: 544-48.
• Attiyeh FF, Stearns MW Jr: Second-look laparotomy based on CEA elevations in colorectal cancer. Cancer 1981; 47: 2119-25.
• Goldberg RM, Fleming TR, Tangen CM et al.: Surgery for recurrent colon cancer: Strategies for identifying resectable recurrence and success rates after resection. Ann Intern Med 1998; 129: 27-35.
• Gunderson LL, Sosin H: Areas of failure found at reoperation (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy. Cancer 1974; 34: 1278-92.
• Lofgren EP, Waugh JM, Dockerty MB: Local recurrence of carcinoma after anterior resection of the rectum and the sigmoid. Arch Surg 1957; 74: 825-38.
• Turnbull RB, Kyle K, Watson FR et al.: Cancer of the colon: The influence of the no-touch isolation technic on survival rates. Ann Surg 1967; 166: 420-27.
• Haugstvedt TK, Viste A, Eide GE et al.: Norwegian multicentre study of survival and prognostic factors in patients undergoing curative resection for gastric carcinoma. Br J Surg 1993; 80: 475-78.
• Sugarbaker PH, Gianola FJ, Speyer JL et al.: Prospective randomized trial of intravenous versus intraperitoneal 5 fluorouracil in patients with advanced primary colon or rectal cancer. Surgery 1985; 98: 414-21.
• Sugarbaker PH: (Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology. In: Sugarbaker PH, (ed.) Peritoneal Carcinomatosis: Principles of Management. Boston: Kluwer; 1996, pp. 79-100.
• Alexander HR, Allegra CJ, Lawrence TS: Metastatic cancer to the liver. In: DeVita VT Jr, Hellman S, Rosenberg SA, (ed.) Cancer: Principles & Practice of Oncology. 6th ed. Philadelphia: JB Lippincott; 2001, pp. 2690-2713.
• Yan TD, Black D, Savady R et al.: Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 2006; 24: 4011-19.
• Swanson RS, Compton CC, Stewart AK et al.: The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 2003; 10: 65.
• Rich T, Gunderson LL, Galdabini J et al.: Clinical and pathologic factors influencing local failure after curative resection of carcinoma of the rectum and rectosigmoid. Cancer 1983; 52: 1317-27.
• Sugarbaker PH: Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 1999; 43 Suppl: S15-25.[Crossref]
• Sugarbaker PH, Gunderson LL, Wittes RE: Colorectal cancer. In: DeVita VT Jr, Hellman S, Rosenberg SA, (ed.) Cancer: Principles and Practice of Oncology. Vol. 1, 2nd ed. Philadelphia: JB Lippincott; 1985, pp. 795-866.
• Rekhraj S, Aziz O, Prabhudesai S et al.: Can intra-operative intraperitoneal free cancer cell detection techniques identify patients at higher recurrence risk following curative colorectal cancer resection: A meta-analysis. Ann Surg Oncol 2007; 15: 60-68.
• da Silva RG, Sugarbaker PH: Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. J Am Coll Surg 2006; 203: 878-86.
• Sugarbaker PH, Jablonski KA: Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995; 221: 124-32.
• Elias D, Goere D, Di Pietrantonio D et al.: Results of systematic second-look surgery in pts at high risk of developing colorectal peritoneal carcinomatosis. Ann Surg 2008; 247: 445-50.[WoS]
• Sugarbaker PH: Monitoring after resection of upper and lower gastrointestinal cancer. In: Wanebo HJ, (ed.) Surgery for Gastrointestinal Cancer: A Multidisciplinary Approach. Philadelphia: Lippincott-Raven Publishers; 1997, pp. 87-95.
• Sugarbaker PH: Peritonectomy procedures. Surg Oncol Clin N Am 2003; 12: 703-27.
• Van der Speeten K, Stuart OA, Sugarbaker PH: Pharmacokinetics and pharmacodynamics of perioperative cancer chemotherapy in peritoneal surface malignancy. Cancer J 2009; 15: 216-24.

Identyfikatory

DOI

10.2478/v10035-010-0078-x